chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE ACUTE NON ST ELEVATION MI
Patient had a syncopal episode and fell off the exam table. He required a visit to the ER for stitches due to a head laceration.
Received vaccine on December 29th have had no issues.  I woke up this morning 1/15/2021  and my right arm was hurting 6/10 on a pain scale.  There was a red rash and I noticed warmth to the injection site.  The rash is located at the injection site and is the size 3*3 circle pattern. I have no other symptoms.
the pharmacist noticed that a "couple of drops" leaked from the injection site; While giving the Vaqta, the pharmacist noticed that a "couple of drops" leaked from the injection site/she was unclear if the medication was leaking from the syringe itself or from the patient's arm; This spontaneous report was received from a pharmacist, regarding a 48-year-old female patient. The patient had no relevant medical history, concomitant medications, or drug history. The patient's concurrent conditions and drug reactions/allergies were not provided.   On 27-APR-2019, the patient was vaccinated with hepatitis a vaccine, inactivated(VAQTA) intramuscularly, 1 milliliter, lot # R025518, for prophylaxis (strength, frequency, anatomical location and expiration date were not provided). Lot No. R025518 has been verified to be a valid lot number for hepatitis a vaccine, inactivated(VAQTA) and even expiration date was not reported, upon internal validation was established as 15-NOV-2019. While giving the hepatitis a vaccine, inactivated(VAQTA) injection, the pharmacist noticed that a "couple of drops" leaked from the injection site (injection site extravasation) and one of these drops hit the floor. However it was unclear if the medication was leaking from the syringe itself or from the patient's arm. The syringe the patient used was a BD lntegra Retractable 3ml, 25 gauge, 1 inch syringe. Because of this the pharmacist wanted to know if the patient should be re-vaccinated. At the reporting time, the outcome of injection site extravasation was unknown.  The reporter did not assess the relatedness between injection site extravasation and the hepatitis a vaccine, inactivated(VAQTA).
27Aug15-9-10 pm, pt noted inj site warm to touch, pink, and swollen. Parent applied warm compress. 28Aug-increase redness (65 x 105 cm), hot to touch. No fever, aches, chills, chest pain.
I went to a conference, I had a scratchy throat that came and went but I decided to come home a day early. I started feeling unwell on June 29, 2022, my energy would go up and down, I would feel nauseous, I had diarrhea, very achy my joints hurt. I used a home COVID-19 test on Sunday July 3, 2022 but it was very faint. Two days later I took another home COVID-19 test that came back positive very fast. I called my doctor who called my back and prescribed PAXLOVID and supplements he recommended I take. By Saturday I started to feel better.
Pt recvd 3 doses of Recombivax 13SEP89, 16OCT89, & 13MAR90 & 28MAR90 titer indicated non-response; 1MAY90 recvd a booster dose Recombivax & 26JUN90 titer indicated non-response; 27NOV90 titer result indicated low response & TB test pos;
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 21Nov2021 as dose 2 (initial pfizer dose), single (Lot number: FH8030) at the age of 55 years, in left arm for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 11Apr2021 as dose 1, single (Lot number: 043A21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "sleep apnea" (unspecified if ongoing); "fatty liver" (unspecified if ongoing); "gallbladder removed" (unspecified if ongoing); "Pulmonary embolism" (unspecified if ongoing); "Hypertensive disorder" (unspecified if ongoing), notes: Hypertensive disorder; "diabetes" (unspecified if ongoing); "Jansen: 11Apr2021/ Pfizer: 21Nov2021" (unspecified if ongoing), notes: Jansen: 11Apr2021/ Pfizer: 21Nov2021; "Blood thinner" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing). Concomitant medication(s) included: XARELTO taken for anticoagulant therapy, start date: Jan2018, stop date: 09May2022; AMLODIPINE taken for blood pressure measurement, start date: Jan2020, stop date: 09May2022; OMEPRAZOLE; METFORMIN. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of suspected covid-19. Clinical course included: COVID-19 was treated with Paxlovid (Lot number FY7031) from 10May2022. On 11May2022 the patient experienced Taste change/bitterness in mouth.
Flu shot 4pm. By 3am I had chills, could not get warm, and was achy. Temperature of 100.4 within 24 hrs felt better.
Headache,eye discomfort behind eyeballs, generalized muscle and body aches-especially back and knees,   chills, fatigue
Initial misuse report received from a health care professional on 26 September 2013. The case was received on 21 March 2014 at GPV. This is an invalid case as individual patient identifiers are not report4ed. FLUZONE ID was given to a patient over 64. (No information was provided regarding the patients). No adverse event was reported. List of documents held by sender: none
This case was reported by a nurse via call center representative and described the occurrence of nausea in a 78-year-old female patient who received SHINGRIX (batch number AS9CM, expiry date unknown). Concomitant products included VALTREX, vitamin D and Oestrogens. On 3rd May 2018, the patient received the 1st dose of SHINGRIX. In May 2018, less than a day after receiving SHINGRIX, the patient experienced nausea, unwell, muscle pain, swelling and lethargy. On an unknown date, the outcome of the nausea, unwell, muscle pain, swelling and lethargy were recovered/resolved. The reporter considered the nausea, unwell, muscle pain, swelling and lethargy to be probably related to SHINGRIX. Additional details were provided as follows: This case was reported by the nurse practitioner. The patient was extremely ill with aching, nausea and lethargy. The patient received the vaccine at a pharmacy. In May 2018, nausea, unwell, muscle pain, swelling and lethargy were resolved.
Pt presented to counter following vaccine, stated he fainted in the chair. Then was monitored for 30 minutes, pt. stated "arms (were) getting tight." Then called Emergency , and pt. left with paramedics.
immediately, within seconds, passed out and fell forward from exam table landing face first on the floor.  Woke up to bleeding from cut lip and front tooth pushed back out of socket.  Per chart Notes:  shook like having a seizer with gargling sound and arms still and tight into body.  Lower lip/chin struck the floor of the clinic, front tooth bent inward, bleeding from laceration.  Called emergency contact (mother) to transport to ER.    Prognosis not good for saving tooth.
shot was given without dilution (0.3ml)  check with patietn several times on day of injection and follow up call the day after  with patgient reporting no ill effects
numbness/tingling or vibrating feeling in lips; numbness/tingling or vibrating feeling in lips; tiredness; light headedness; tingling sensation has spread to my entire body.; This is a spontaneous report from a contactable consumer (patient).   A 49-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EN6202, Expiration date was not reported), via an unspecified route of administration (administered on the right arm) on 02Mar2021 10:00 (at the age of 49-years-old) as unknown, single dose for COVID-19 immunisation. Medical history included diabetes mellitus, arthritis, morbid obesity, alopecia areata, psoriasis and sensitivity to glues used in band aids and other chemical sensitivities; all from an unknown date. Concomitant medications included glyburide, sitagliptin (JANUVIA), insulin aspart (NOVOLOG), insulin detemir (LEVEMIR) and telmisartan all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient has not been diagnosed with COVID-19. On 02Mar2021 10:30, the patient experienced numbness/tingling or vibrating feeling in lips, tiredness and light headedness; tingling sensation has spread to my entire body on 02Mar2021. It was reported that numbness/tingling or vibrating feeling in lips occurred at just over half hour after dose. By end of the day the tingling sensation has spread to the entire body. The tingling was not over whelming but definitely there. The patient has also experienced tiredness and light headedness but to a minor degree. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information expected.
Received injection approx 10am on 9-6-06, that afternoon arm became tender to touch. Arm still aches this day, no redness or swelling or fever.
This spontaneous report was received from a registered nurse via a company representative with none drug reactions or allergies. The patient's medical history and concurrent conditions were not reported. It was reported that the patient was vaccinated with her first dose of PNEUMOVAX23 about 5 years ago. On 19-OCT-2015, the patient was vaccinated with the second dose of PNEUMOVAX23, 0.5 ml, intramuscular, at the arm, lot number L003188, expiration date 06-JUL-2016. The patient's concomitant therapies included unspecified OTC (over the counter) cold medicine. On an unknown date in 2015, the patient came into the office for follow up since her arm was completely red from deltoid area all the way down to elbow (injection site reaction). The patient stated that her arm was very painful (pain in extremity) ad hot to touch and she also experienced some nausea. The patient was treated with TYLENOL. The nurse stated that she was going to discontinue the PNEUMOVAX23 with the lot number L003188. At the time of the report, the outcome of her arm was completely red from deltoid area all the way down to elbow and hot to touch and the nausea was reported as not recovered. This is one of several reports from the same source. Additional information has been requested.
I received my first shot on 2/4 and I developed Bell's Palsy on 3/2 on the left side of my face  I received my second shot on 3/9 and I developed Tinnitus on 3/22 in my left ear  The Emergency Room Doctor prescribed prednisone and an antiviral for 1 week and over the counter drops for my eye  After about 7 weeks my Bell's Palsy and eye are about 80%  The Tinnitus remains
Fever 104-105 R 430AM 7NOV91; vomitted only once 8AM p/bottle; 1045AM t100 (ear) 7NOV91; pt temp started 6NOV91 103 @ 3PM R;
pt recv vax 15JUN98 & mom noticed little red bumps @ bath time-next day had white head & hard nodules located on upper back, under arm & trunk area;dx spider bites & given ATB;turned brown & opened w/clear drainage;
Patient was evaluated in the ED less than 24 hours after receiving the vaccines for sx of fever, cough. Temp noted at 100.9. Cough described as 'barky'. DX with Croup.  It was later found during routine vaccine inventory check that the Hib was not reconstituted with the supplied diluent (0.4% Sodium Chloride)
Dizziness, Diarrhea, NauseaVomiting, Tachycardia, paresthesia in left arm and leg, seeing spots, HR 179/117 Narrative:  Other Relevant History:
Information has been received from a health professional concerning an 8-year-old female with no pre-existing allergies, birth defects, or medical conditions, who on 18-DEC-1997 was vaccine with a second dose of varicella virus vaccine live (Oka/Merck). There was no illness at the time of vaccination. On 07-NOV-2007, the patient broke-out with a mild case of chickenpox. The patient used calamine lotion, Aveeno and Benadryl. Subsequently, the patient recovered. There were no relevant diagnostic tests or laboratory data. There were no adverse events following prior vaccinations. Additional information has been requested.
4/24 ? first vaccine at 2:00 pm  5/15 ? second dose at 2:00   After receiving second shot, during waited 15 minutes and felt dizzy during the wait period but came home because son drove me to the appointment.  That night, I felt very dizzy and had cold symptoms so took Tylenol every six hours ? from May 15 ? 21st.   I could not volunteer/work because of poor health conditions after getting vaccine and took a leave of absence.   I felt okay afterwards until June 1st. On June 1st, my left eye was swollen and my eye felt fatigued. I rested my eyes but started losing vision little by little in my left eye. On June 5th, my left eye hurt severely. I made appointment with an optometrist on June 6th and saw the optometrist on 7th at noon.  During the check up, the doctor reported that the blood vessels had ruptured behind my cornea and the inside of my eye was filled with blood. He was not equipped to handle this situation so he gave referral to an eye specialist (for special eye part) and went to an appointment on June 10th.  When I went to the specialist, he reported that the inside of eye was filled with blood, which was causing the blindness. He performed laser treatment and advised that I return for a check up after 5 weeks and advised to stay at home, no driving, avoid bright lights, etc. I followed the doctor's orders and stayed home for 5 weeks.   I returned to the eye specialist for my 5-week check up on July 15th and the doctor reported that the condition has not gotten better. I still could not see from left eye. The doctor performed a second laser treatment on the 15th and advised to return for check-up after 6 weeks because of the severity of the condition. The doctor said that I needed extra time to recover. If conditions do not improve, he said that I will need to get surgery and additional treatment for my eye sight to return.  I am currently 1 week into the second laser treatment and my condition has not improved.
On 4.15.2021  I began to have a congestion  ( phlegm) , a scratchy throat ,  swollen around the eyes and a sweaty cols clammy feeling.  I took a Excedrin PM   and Allergy Tab ( antihistamine)  to re leave the symptoms ..   4.16.2021  and 4.17.2021  it seem better with just runny nose and   swollen around the eyes  persisting.     I am guessing by reading  forms on the Vaccine  this is a reaction to the Vaccine working ?    as a note I have not had allergy's  in the past  of this ..   I also do not have heath insurance  As I can not afford it .. this was a free Vaccination..
A report was received from a health care professional on 11/21/03 concerning a 48 year old female vaccinee who experienced labyrinthitis after she received Fluvirin on 11/17/03. On 11/17/03 the vaccinee received Fluvirin. One hour after vaccination the vaccinee felt limp and weak in her extremities and head but not dizzy. The vaccinee could not walk and went to the emergency room and was diagnosed with labyrinthitis. On 11/18/03 the vaccinee experienced the same symptoms again. On 11/19/03 the vaccinee did not have any symptoms when her physician advised her not to take her other medications. On 11/20/03 the vaccinee experienced 2 episodes of the same symptoms and also had difficulty in holding up her head. On 11/21/03 the vaccinee experienced 1 episode of the same symptoms with less difficulty in holding up her head. On 11/25/03 the vaccinee 's condition had greatly improved. There was insufficient information to determine the reporter's causality assessment. Update 2/2/04: A follow up report was received from a health care professional indicating that the vaccinees symptoms had resolved 8 days after onset, when the schedule of the vaccinees medications was changed. The medications are Valproic Acid, Venlafaxine HCl and Amitriptyline. No follow up pending, all information received.
8/2/21 AT 5:55PM PATIENT CAME TO THE PHARMACY TO BUY AN OTC ITEM AND TOLD ME THAT SHE GOT HOSPITALIZED 30 DAYS AFTER THE SECOND DOSE (4/19/2021). SHE WAS IN THE HOSPITAL FOR 15 DAYS DUE TO CONGESTIVE HEART FAILURE. WAS TOLD THAT SHE IS NOW UNDER THE CARE OF A CARDIOLOGIST AND RECEIVES INFUSION FOR HER HEART (SHE SOESNT KNOW WHAT IT IS). SHE SAID IT WAS PROBABLY CAUSED BY THE VACCINE. [ NOTE: ON 4/19/21 WHEN PATIENT CAME IN FOR HER SECOND DOSE, SHE SHOWED ME "DRIED" RASHES ON HER WAISTLINE WHICH WENT ALL THE WAY TO HER BACK WAIST. SHE DOESNT REALLY KNOW IF ITS FROM THE VACCINE OR NOT OR FROM HER MEDICINE'S SIDE EFFECTS. THE RASH APPEARED 3-4 DAYS AFTER THE 1ST DOSE. SHE STATED THAT ONE OF THE SIDE EFFECTS OF HER MEDS IS RASH (WHICH SHE DID NOT KNOW THE NAME OF THE DRUG THAT CAUSES IT). I TOLD HER THAT I CAN CALL THE MANUFACTURER TO GET MORE GUIDANCE. SHE SATTED TO JUST GIVE THE MODERNA 2ND DOSE SINCE SHE WASNT REALLY SURE IF THE RASHES ARE FROM THE VACCINE OR NOT. I TOLD HER THAT WITH JUST THE 1ST DOSE, SHES ALREADY ABOUT 80% PROTECTED. PATIENT SAID SHE REALLY WANT TO GET THE 2ND DOSE). I GAVE HER THE SECOND DOSE AND DID NOT HEAR FROM HER UNTIL YESTERDAY (WHICH IS 3.5 MONTHS LATER)
Sensory GUILLAIN-BARRE - severe pain in legs and hips for four days until diagnosed. TX: LYRICA 150mg 31 day, tramadol 50 mg every 6 hrs, weakness in legs continues/ IVIG -  4 day series plus 1 booster.
Fever for 36 hours, head, muscle, joint pain, weakness (unable to walk without support for 30 hours, fatigue lasting three days. Temp=100?
received 2nd Moderna vaccine on Wed, 4/21.  along with expected reactions (chills, body aches, headache, joint pain) also expereinced swelling in facial areas where filler had been injected 6-12 months prior.  did not experience any side effects with 1st shot.   additionally, the onset of a dry cough occurred, which i hope is a coincidence but it is still here 3 days later.  other reactions have subsided.  swelling in filler area is almost gone.   cough is same or slightly worse.
Expired dose administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 1-year-old male patient who received DTPa (Infanrix) (batch number XG942, expiry date 22nd August 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 26th September 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 26th September 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 28-Sept-2022 Reporter's comment: The reporter reported expired Infanrix administered to a patient. Additional supportive information: The patient received an expired dose of Infanrix, which led to expired vaccine used.
Patient received the vaccine and seemed fine but then noticed a little bit of blood under the band-aid. He got very upset about the blood. He walked out of the room while I was giving his brother a vaccine. A few minutes later my technician told me patient had passed out at the U-scan in store and was at the little clinic next door. The store manager was aware of incident as well. Parents did not want us to contact ambulance and wanted to take the kids home. Patient was very upset about his vaccine and was crying. Parents think he hit his head when he had syncopal episode. This whole incident happened around noon. Syncope happened within 5-10 minutes of injection. I spoke with the dad around 2pm and he said they are taking patient to hospital because after a nap, patient vomited a little around 1:30pm. They are taking him just in case he has a concussion from the fall.
Dizziness, nerve pain, vomiting, injection site swelling and blistering, knot in injection site
Chills,  fever,  malaise , shaking for 24 hrs, no cough. Had urisx prior to vaccine, Chest congestion no sore throat, no cough. Everything after injection 10/08/2008
fast heart beat,  hard time breathing, extreme dizziness, itching, near fainting spells,
-Blotchy skin rash on torso, legs, neck, arms.  -Nausea, heartburn.  -Ache at site of injection  (50mg Diphenhydramine, 400mg Ibuprofen)
covid_test_date= 18Nov2021, covid_test_result=Positive; covid_test_date= 18Nov2021, covid_test_result=Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Nov2021 18:00 (Lot number: 3203080) at the age of 43 years as dose 3 (booster), single, administered in arm left, administration date 20Apr2021 12:00 (Lot number: EN0172) as dose 2, single and administered in arm left, administration date 30Mar2021 12:00 (Lot number: ER8734) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (unspecified if ongoing); "GERD" (unspecified if ongoing). Concomitant medication(s) included: ESCITALOPRAM. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 18Nov2021, outcome "unknown" and all described as "covid_test_date= 18Nov2021, covid_test_result=Positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (18Nov2021) positive, notes: COVID test type post vaccination: Nasal Swab.  No follow-up attempts are possible. No further information is expected.
30 seconds following IM injection, felt warm, flushed, lightheaded, vision dimming., near syncope. Symptoms improved lying supine. Blood pressure measured to be 90's systolic, Heart Rate 60's. NO RASH, NO ANGIOEDEMA, NO Shortness of breath. Symptoms resolved completely within in 3 minutes.
Received vaccination 12/23/20. On 12/28/20 began having fever 102+ and shortness of breath. Decided to go to ED for evaluation and COVID tested. Discharged from ED.
falling; This case was reported by a physician via call center representative and described the occurrence of fall in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced fall. On an unknown date, the outcome of the fall was unknown.   It was unknown if the reporter considered the fall to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient fell and broke his or her nose.  The doctor would not provide any additional information.  The reporter did not consent to follow-up.
This spontaneous report as received from a registered nurse via field representative refers to a 64 years old female patient. The patient's medical history and concurrent conditions were not reported. On 12-MAY-2016 the patient was inadvertently vaccinated with a dose of VARIVAX instead of an intended dose of ZOSTAVAX (wrong drug administered). The reason for the error was unspecified. No adverse effects reported. The outcome of the events was unknown. Additional information had been requested.
On the location of the shot a big bump has popped up feels like its getting bigger, and theres a slight pain when i put pressure on it. Its been almost 3 months since i got the vaccine and i didnt notice the bump till this month.